Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label, Phase II Safety, Tolerability, Drug Level and Efficacy Trial of Quinacrine in Patients With Androgen-Independent Metastatic Prostate Cancer

NCT00417274 is registered in ClinicalTrials.gov with Cleveland BioLabs as lead sponsor.

NCT NCT00417274
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00417274 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label, Phase II Safety, Tolerability, Drug Level and Efficacy Trial of Quinacrine in Patients With Androgen-Independent Metastatic Prostate Cancer
Lead sponsor
Cleveland BioLabs
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2006
Completion date
May 31, 2008
Enrollment
31 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

prostatic cancer